Early and late effects of neoadjuvant hormonal therapy on prostate specific antigen and prostate volume following permanent seed implantation for prostate carcinoma

Initial decline in hemoglobin during neo

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

✍ Anthony V. D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A. Renshaw; Daniel Geor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could